Evaluating the Necessity of TOT Implantation in Women With Pelvic Organ Prolapse and Occult Stress Urinary Incontinence
ATHENA
1 other identifier
interventional
21
1 country
1
Brief Summary
Nowadays the clinical significance of an occult stress urinary incontinence and its optimal treatment is not known.Regarding treatment, there are 2 main approaches : either the systematic preventive treatment of the occult stress urinary incontinence by means of a tension free vaginal tape (TOT) together with the treatment of prolapse or the treatment of prolapse in the first place and treatment of stress incontinence in a second time when and if it appears.This study is expected to provide objective evidence concerning the efficacy and security of TOT implantation for the prevention treatment of occult stress urinary incontinence in women with pelvic organ prolapse and occult urinary incontinence.The perspective is to improve the management of these patients by providing evidence based recommendation for their treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2010
CompletedFirst Posted
Study publicly available on registry
March 30, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedJune 6, 2014
June 1, 2014
3 years
March 29, 2010
June 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the postoperative prevalence of stress incontinence in patients with or without TOT implant during a pelvic organ prolapse surgery
6 month
Secondary Outcomes (9)
To compare the severity of postoperative stress urinary incontinence between the two groups
6 month
To compare the prevalence of new onset overactive bladder postoperatively between the two groups
6 month
To compare the severity of new onset overactive bladder between the two groups
6 month
To compare the prevalence of postoperative dyspareunia at 6 months between the two groups
6 month
To compare the prevalence of postoperative urinary retention between the two groups
6 month
- +4 more secondary outcomes
Study Arms (2)
only surgery
ACTIVE COMPARATORsurgery + TOT
EXPERIMENTALInterventions
Procedure/Surgery: Pelvic Organ Prolapse intervention and Suburethral TOT implantation
Procedure/Surgery: Pelvic Organ Prolapse intervention
Eligibility Criteria
You may qualify if:
- Female patients, at least 18 years of age
- Having a pelvic organ prolapse and occult stress urinary incontinence
- Patient non opposed to the exploitation of data in research
- Agree to comply with all protocol-specified procedures, including protocol mandated follow up visits
You may not qualify if:
- Symptoms of stress urinary incontinence preoperatively
- Patients not having social security
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diaconesses Hospital
Paris, Île-de-France Region, 75012, France
Related Publications (3)
Cortesse A, Jacquetin B, Grise P, Le Normand L, Richard F, Haab F. Prospective multicenter clinical trial of Uretex Sup for surgical treatment of stress urinary incontinence. Int J Urol. 2007 Jul;14(7):611-5. doi: 10.1111/j.1442-2042.2007.01542.x.
PMID: 17645604RESULTYeung E, Baessler K, Christmann-Schmid C, Haya N, Chen Z, Wallace SA, Mowat A, Maher C. Transvaginal mesh or grafts or native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2024 Mar 13;3(3):CD012079. doi: 10.1002/14651858.CD012079.pub2.
PMID: 38477494DERIVEDMaher C, Yeung E, Haya N, Christmann-Schmid C, Mowat A, Chen Z, Baessler K. Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev. 2023 Jul 26;7(7):CD012376. doi: 10.1002/14651858.CD012376.pub2.
PMID: 37493538DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ariane Cortesse, MD
Department of Urology, Saint Louis Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2010
First Posted
March 30, 2010
Study Start
July 1, 2010
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
June 6, 2014
Record last verified: 2014-06